FDA Drug recall D-0219-2024
Tacrolimus Capsules, USP 1mg, 100-Count Bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited, Bachupally, 500 090, INDIA, ND…
- FDA Drug
- Class II
- terminated
- Published 2024-01-17
On 2024-01-17 the FDA classified a Class II recall of Tacrolimus Capsules, USP 1mg, 100-Count Bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited, Bachupally, 500 090, INDIA, ND… by Dr Reddy S Laboratories, citing presence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrolimus capsules.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0219-2024 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2023-12-15 |
| Published | 2024-01-17 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Dr Reddy S Laboratories |
| Distribution | US |
Product
Tacrolimus Capsules, USP 1mg, 100-Count Bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited, Bachupally, 500 090, INDIA, NDC 55111-526-01
Reason
Presence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrolimus capsules.
Identifiers
| ndc | 55111-525-30 |
|---|---|
| ndc | 55111-525-01 |
| ndc | 55111-525-05 |
| ndc | 55111-525-79 |
| ndc | 55111-525-78 |
| ndc | 55111-526-30 |
| ndc | 55111-526-01 |
| ndc | 55111-526-05 |
| ndc | 55111-526-79 |
| ndc | 55111-526-78 |
| ndc | 55111-527-30 |
| ndc | 55111-527-01 |
| ndc | 55111-527-05 |
| ndc | 55111-527-79 |
| ndc | 55111-527-78 |
| code_info | Lot# C2307275; Exp. January 2026 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0219-2024%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.